Literature DB >> 20017186

Case-control study of pleural mesothelioma in workers with social security in Mexico.

Guadalupe Aguilar-Madrid1, Eduardo Robles-Pérez, Cuauhtémoc Arturo Juárez-Pérez, Isabel Alvarado-Cabrero, Flavio Gerardo Rico-Méndez, Kelly-García Javier.   

Abstract

BACKGROUND: Environmental and occupational exposure to asbestos in Mexico in the past has been a cause of deaths and health damages. Its magnitude is unknown to date. Our objective was to identify the proportion of cases of malignant pleural mesothelioma (MPM) that can be attributed to and occupational exposure to asbestos.
METHODS: We carried out a case-control study of MPM in 472 workers insured by the Mexican Institute of Social Security, all Valley of Mexico residents, with 119 incident cases and 353 controls. Cases were histologically confirmed. Participants were questioned concerning their occupational history and sociodemographic data. Assignment to one of the four exposures was performed qualitatively by an expert hygienist. Odds ratios (ORs) and attributable risks (ARs) were calculated using a non-conditional logistic regression model.
RESULTS: A total of 80.6% of cases and 31.5% of controls had occupational exposure to asbestos. ORs were adjusted for age and gender and by exposure category, and exhibited an increase with probability of exposure as follows: 3.7(95% CI 1.3-10.4) for the likely category and 14.3(95% CI 8-26) for the certain category; AR in the group occupationally exposed to asbestos was 83.2%, and the population AR was 44%.
CONCLUSIONS: Our results show that the relationship between industrial uses of all forms of asbestos is generating an increase in mesothelioma-related diseases and deaths among Mexican workers. As a public health policy, Mexico should prohibit the use of asbestos in all production processes with the aim of controlling the epidemic and preventing the occurrence of new cases of MPM. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20017186     DOI: 10.1002/ajim.20780

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  11 in total

1.  Mesothelin, Calretinin, and Megakaryocyte Potentiating Factor as Biomarkers of Malignant Pleural Mesothelioma.

Authors:  Carmina Jiménez-Ramírez; Swaantje Casjens; Cuauhtémoc Arturo Juárez-Pérez; Irina Raiko; Luz M Del Razo; Dirk Taeger; Emma S Calderón-Aranda; Hans-Peter Rihs; Leonor Concepción Acosta-Saavedra; Daniel Gilbert Weber; Alejandro Cabello-López; Beate Pesch; María Dolores Ochoa-Vázquez; Katarzyna Burek; Luis Torre-Bouscoulet; José Rogelio Pérez-Padilla; Erik Marco García-Bazan; Thomas Brüning; Georg Johnen; Guadalupe Aguilar-Madrid
Journal:  Lung       Date:  2019-07-02       Impact factor: 2.584

Review 2.  Recent Scientific Evidence Regarding Asbestos Use and Health Consequences of Asbestos Exposure.

Authors:  Manuela Valenzuela; Margarita Giraldo; Sonia Gallo-Murcia; Juliana Pineda; Laura Santos; Juan Pablo Ramos-Bonilla
Journal:  Curr Environ Health Rep       Date:  2016-12

Review 3.  Health risk of chrysotile revisited.

Authors:  David Bernstein; Jacques Dunnigan; Thomas Hesterberg; Robert Brown; Juan Antonio Legaspi Velasco; Raúl Barrera; John Hoskins; Allen Gibbs
Journal:  Crit Rev Toxicol       Date:  2013-02       Impact factor: 5.635

4.  Massive localized malignant pleural mesothelioma (LMPM): manifestations on computed tomography in 6 cases.

Authors:  Weigen Yao; Hanqing Yang; Guolai Huang; Yang Yan; Honglin Wang; Dongfang Sun
Journal:  Int J Clin Exp Med       Date:  2015-10-15

5.  Environmental occurrence, origin, physical and geochemical properties, and carcinogenic potential of erionite near San Miguel de Allende, Mexico.

Authors:  M Adrián Ortega-Guerrero; Gerardo Carrasco-Núñez
Journal:  Environ Geochem Health       Date:  2013-11-24       Impact factor: 4.609

Review 6.  Prevention of Asbestos Exposure in Latin America within a Global Public Health Perspective.

Authors:  Eduardo Algranti; Juan Pablo Ramos-Bonilla; Benedetto Terracini; Vilma S Santana; Pietro Comba; Roberto Pasetto; Agata Mazzeo; Fulvio Cavariani; Andrés Trotta; Daniela Marsili
Journal:  Ann Glob Health       Date:  2019-03-29       Impact factor: 2.462

7.  Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma.

Authors:  Oscar Arrieta; Wendy Muñoz-Montaño; Sae Muñiz-Hernández; Saul Campos; Rodrigo Catalán; Herman Soto-Molina; Silvia Guzmán Vázquez; Osvaldo Díaz-Álvarez; Victor Martínez-Pacheco; Jenny G Turcott; Maritza Ramos-Ramírez; Luis Cabrera-Miranda; Feliciano Barrón; Andrés F Cardona
Journal:  Front Oncol       Date:  2021-04-20       Impact factor: 6.244

8.  RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin.

Authors:  Wendy Muñoz-Montaño; Sae Muñiz-Hernández; Alejandro Avilés-Salas; Rodrigo Catalán; Luis Lara-Mejía; Suraj Samtani-Bassarmal; Andres F Cardona; Jorge Mendoza-Desión; Daniel Hernández-Cueto; Altagracia Maldonado; Guillermina Baay-Guzmán; Sara Huerta-Yepes; Oscar Arrieta
Journal:  BMC Cancer       Date:  2021-08-05       Impact factor: 4.430

Review 9.  Prevention of Asbestos-Related Disease in Countries Currently Using Asbestos.

Authors:  Daniela Marsili; Benedetto Terracini; Vilma S Santana; Juan Pablo Ramos-Bonilla; Roberto Pasetto; Agata Mazzeo; Dana Loomis; Pietro Comba; Eduardo Algranti
Journal:  Int J Environ Res Public Health       Date:  2016-05-12       Impact factor: 3.390

10.  Biomarkers for Predicting Malignant Pleural Mesothelioma in a Mexican Population.

Authors:  Guadalupe Aguilar-Madrid; Beate Pesch; Emma S Calderón-Aranda; Katarzyna Burek; Carmina Jiménez-Ramírez; Cuauhtémoc Arturo Juárez-Pérez; María Dolores Ochoa-Vázquez; Luis Torre-Bouscoulet; Leonor Concepción Acosta-Saavedra; Isabel Sada-Ovalle; Jorge García-Figueroa; Isabel Alvarado-Cabrero; Patricia Castillo-González; Alejandra Renata Báez-Saldaña; José Rogelio Pérez-Padilla; Juvencio Osnaya-Juárez; Rosa María Rivera-Rosales; Eric Marco García-Bazán; Yolanda Lizbeth Bautista-Aragón; Elimelec Lazcano-Hernandez; Daniel Alejandro Munguía-Canales; Luis Marcelo Argote-Greene; Dirk Taeger; Daniel Gilbert Weber; Swaantje Casjens; Irina Raiko; Thomas Brüning; Georg Johnen
Journal:  Int J Med Sci       Date:  2018-06-04       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.